Collins LE - Search Results

1

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.

Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Müller CE, Salamone JD. Mott AM, et al. Among authors: collins le. Psychopharmacology (Berl). 2009 May;204(1):103-12. doi: 10.1007/s00213-008-1441-z. Epub 2009 Jan 9. Psychopharmacology (Berl). 2009. PMID: 19132351 Free PMC article.

2

Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.

Sink KS, Segovia KN, Nunes EJ, Collins LE, Vemuri VK, Thakur G, Makriyannis A, Salamone JD. Sink KS, et al. Among authors: collins le. Psychopharmacology (Berl). 2009 Oct;206(2):223-32. doi: 10.1007/s00213-009-1602-8. Epub 2009 Jul 10. Psychopharmacology (Berl). 2009. PMID: 19588124 Free PMC article.

3

Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.

Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD. Farrar AM, et al. Among authors: collins le. Neuroscience. 2010 Apr 14;166(4):1056-67. doi: 10.1016/j.neuroscience.2009.12.056. Epub 2010 Jan 20. Neuroscience. 2010. PMID: 20096336

4

Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.

Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN. Salamone JD, et al. Among authors: collins le. Behav Brain Res. 2009 Jul 19;201(1):216-22. doi: 10.1016/j.bbr.2009.02.021. Epub 2009 Mar 3. Behav Brain Res. 2009. PMID: 19428636 Free PMC article.

5

Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.

Collins LE, Galtieri DJ, Brennum LT, Sager TN, Hockemeyer J, Müller CE, Hinman JR, Chrobak JJ, Salamone JD. Collins LE, et al. Pharmacol Biochem Behav. 2010 Feb;94(4):561-9. doi: 10.1016/j.pbb.2009.11.011. Epub 2009 Dec 1. Pharmacol Biochem Behav. 2010. PMID: 19958787

6

Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.

Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE, Hockemeyer J, Müller CE, Salamone JD. Collins LE, et al. Among authors: collins p. Behav Brain Res. 2010 Aug 25;211(2):148-55. doi: 10.1016/j.bbr.2010.03.003. Epub 2010 Mar 6. Behav Brain Res. 2010. PMID: 20211657

7

The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.

Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD. Collins LE, et al. Pharmacol Biochem Behav. 2012 Jan;100(3):498-505. doi: 10.1016/j.pbb.2011.10.015. Epub 2011 Oct 20. Pharmacol Biochem Behav. 2012. PMID: 22037410

8

Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

Sink KS, Segovia KN, Sink J, Randall PA, Collins LE, Correa M, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. Sink KS, et al. Among authors: collins le. Eur Neuropsychopharmacol. 2010 Feb;20(2):112-22. doi: 10.1016/j.euroneuro.2009.11.002. Epub 2009 Dec 16. Eur Neuropsychopharmacol. 2010. PMID: 20015619 Free PMC article.

9

The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats.

Sink KS, Segovia KN, Collins LE, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD. Sink KS, et al. Among authors: collins le. Pharmacol Biochem Behav. 2010 Jun;95(4):479-84. doi: 10.1016/j.pbb.2010.03.011. Epub 2010 Mar 27. Pharmacol Biochem Behav. 2010. PMID: 20347865 Free PMC article.

10

Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.

Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD. Collins LE, et al. Pharmacol Biochem Behav. 2011 Sep;99(3):414-22. doi: 10.1016/j.pbb.2011.05.026. Epub 2011 May 27. Pharmacol Biochem Behav. 2011. PMID: 21640750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page